Securities adjusted its outlook on Sage Therapeutics (NASDAQ:SAGE) shares, with analyst Vamil Divan increasing the price target to $9.00 from the previous $6.00, while maintaining a Neutral rating on ...

Equities research analysts at Seaport Res Ptn issued their FY2024 earnings per share (EPS) estimates for shares of Plug Power in a research note issued to investors on Monday, January 27th. Seaport ...

US stocks rose on Thursday, with the Nasdaq (^IXIC) and S&P 500 (^GSPC) eyeing a comeback as investors digested news that the ...

BT and Shell shares are in the spotlight at the start of the FTSE 100 results season. The oil giant boosted shareholder ...

Barclays analyst Sven Merkt maintained a Sell rating on Sage Group plc (SGE – Research Report) today and set a price target of £10.80. The ...

We recently compiled a list of the Morgan Stanley’s 15 Best European AI Stocks. In this article, we are going to take a look ...

Jefferies raised the firm’s price target on Sage Group (SGPYY) to 1,600 GBp from 1,500 GBp and keeps a Buy rating on the shares. The “most ...

In a report released today, Kai Korschelt from Canaccord Genuity reiterated a Sell rating on Sage Group plc (SGE – Research Report), with a ...

Procurement solutions are notorious for their gaps. Teams struggle to create manual workarounds between disconnected systems ...

Inovio Pharmaceuticals Inc.-3.52% $81.95M ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...